EUVIMEDEUVIMED entdecken
Crossref

Effectiveness of Hapo Chamber Ventilation on Acute High Altitude Sickness: An Observational Study

Dharmendra Kanwaria, Nitesh K. Bauddh, Mubashir R. Zaboo, Ravi K. Bharti

International Journal of Current Pharmaceutical Review and Research · 30.07.2026 · 18 (07)

DOI: 10.25258/ijcpr.18.7.120 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Current Pharmaceutical Review and Research, online erschienen am 30.07.2026. Verfasst von Dharmendra Kanwaria und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

To assess the role of non-pharmacological method (one man HAPO chamber ventilation) in the treatment of High Altitude Sickness (HAS) for a period until descent of patient.

Method

The study region was Panchtarni base camp of Shri Amarnath Yatra-2016. Patients were come for medical assistance for different of complains at Panchtarni base camp hospital. They were assessed for symptoms and signs of High Altitude Sicknesses [AMS (Acute Mountain Sickness)/HACE (High Altitude Cerebral Edema)/HAPE (High Altitude Pulmonary Edema)] according to LAKE LOUISE SCORING SYSTEM. One man HAPO chamber ventilation (HCV) were used for 32 patients with moderate-severe AMS, HACE and HAPE after medical treatment. Pre and post-HCV Parameters (Vitals, SPO2, Lake Louise Score) were recorded and analysis was done.

Result

The clinical score, Lake Louise Score, which is the morbidity indicator of High altitude sickness was significantly reduced (Mean difference 3.97, 95%CI 3.45-4.48) after one man chamber HAPO ventilation along with significant improvement in SPO2 and vitals.

Conclusion

Inadequate acclimatization remains the most significant risk factor for developing HAS. Clinicians advising individuals, who are preparing to travel to high altitude, should provide education about the importance of slow graded ascent. Immediate descent and administration of supplemental oxygen to raise saturation levels above 90% continue to be the definitive treatments for HAS. The use of portable hyperbaric chamber may be an effective temporizing measure along with Nifedipine, Dexamethasone and/or Acetazolamide as an adjunctive treatment.

Zitieren

APA

Kanwaria, D., Bauddh, N. K., Zaboo, M. R., & Bharti, R. K. (2026). Effectiveness of Hapo Chamber Ventilation on Acute High Altitude Sickness: An Observational Study. International Journal of Current Pharmaceutical Review and Research, 18(07). https://doi.org/10.25258/ijcpr.18.7.120

Vancouver

Kanwaria D, Bauddh NK, Zaboo MR, Bharti RK. Effectiveness of Hapo Chamber Ventilation on Acute High Altitude Sickness: An Observational Study. International Journal of Current Pharmaceutical Review and Research. 2026;18(07). doi:10.25258/ijcpr.18.7.120

BibTeX
@article{Kanwaria2026,
  author = {Kanwaria, Dharmendra and Bauddh, Nitesh K. and Zaboo, Mubashir R. and Bharti, Ravi K.},
  title = {Effectiveness of Hapo Chamber Ventilation on Acute High Altitude Sickness: An Observational Study},
  journal = {International Journal of Current Pharmaceutical Review and Research},
  year = {2026},
  volume = {18},
  number = {07},
  doi = {10.25258/ijcpr.18.7.120}
}
Kostenlos starten →